Comparison of Basal Neuropeptide Y and Corticotropin Releasing Factor Levels Between the High Ethanol Drinking C57BL/6J and Low Ethanol Drinking DBA/2J Inbred Mouse Strains
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent genetic and pharmacological evidence indicates that low neuropeptide Y (NPY) levels in brain regions involved with neurobiological responses to ethanol promote increased ethanol consumption. Because of their opposing actions, it has been suggested that NPY and corticotropin releasing factor (CRF) exert a reciprocal regulation on drug self-administration. It has been widely reported that inbred C57BL/6 mice consume significantly higher amounts of ethanol than do DBA/2 mice. Therefore, we used immunohistochemical techniques to determine if basal NPY and/or CRF levels differed in predicted directions between C57BL/6J and DBA/2J mice. METHODS: Ethanol-naive C57BL/6J and DBA/2J mice were deeply anesthetized with sodium pentobarbital (100 mg/kg) and perfused transcardially with 0.1 mM of phosphate-buffered saline followed by 4% paraformaldehyde in buffered saline. Brains were collected and postfixed for 4 hr at 4 degrees C and then were cut into 35-microm sections. Tissues containing the nucleus accumbens (NAc), hypothalamus, and amygdala were processed for NPY or CRF immunoreactivity using immunofluorescent or DAB techniques. Immunoreactivity was quantified from digital images using Image J software. RESULTS: The C57BL/6J mice showed reduced NPY expression in the NAc shell, the basolateral amygdala, and the central nucleus of the amygdala when compared with DBA/2J mice. However, these strains did not differ in CRF expression in any of the brain regions analyzed. CONCLUSIONS: These data suggest that low NPY levels in the amygdala and/or the shell of the NAc, which are not compensated for by similar changes in CRF levels, may contribute to the high ethanol consumption characteristic of C57BL/6J mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953 · cited 1×
“Corticotropin releasing factor (CRF) is a 41 amino acid polypeptide that is expressed in many of the same brain regions as NPY, including the hypothalamus and amygdala (Swanson et al., 1983).”
BackgroundLow level of response to alcohol as a predictor of future alcoholism
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.184 · Cited by 826 · cited 1×
“There is increasing evidence from both human and animal research indicating that resistance to the intoxicating effects of ethanol is often associated with high levels of ethanol drinking (Schuckit, 1986, 1988, 1994).”
BackgroundPich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · cited 1×
“Thus, after ethanol withdrawal, there are low levels of NPY (Pandey et al., 2003b; Roy and Pandey, 2002) and increased levels of CRF (Merlo Pich et al., 1995) in the amygdala.”
BackgroundAlcohol and tension reduction. A review
Cappell, H., & Herman, C. P. (1972) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1972.33.033 · Cited by 433
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387 · cited 2×
“…in high ethanol drinking models (Badia-Elder et al., 2003; Badia-Elder et al., 2001; Gilpin et al., 2003), central infusion of the CRF receptor antagonist D-Phe-CRF(1,2-14) eliminates excessive ethanol drinking by rats made dependent with chronic exposure to ethanol vapor (Valdez et al., 2002).”
BackgroundPandey, S. C., Roy, A., & Zhang, H. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000056616.81971.49 · Cited by 168 · cited 5×
“In addition, amygdalar infusion of a PKA inhibitor causes local reductions of NPY levels that are associated with increased ethanol intake in Sprague Dawley rats, and furthermore, elevated levels of ethanol drinking are rescued by amygdalar coadministration of NPY (Pandey et al., 2003b).”
BackgroundInfluentialSB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130 · cited 2×
“Furthermore, central infusion of NPY (Pandey et al., 2003b) or CRF receptor antagonists (Breese et al., 2004; Knapp et al., 2004; Overstreet et al., 2004; Rassnick et al., 1993) reverses the anxiogenic effect of ethanol withdrawal.”
BackgroundSelf-citationVrang, N., Larsen, P. J., & Mikkelsen, J. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)00425-p · Cited by 123 · cited 1×
“As an alternative region, we quantified CRF IR in the suprachiasmatic nucleus of the hypothalamus because the suprachiasmatic nucleus is a major source of CRF that innervates the paraventricular nucleus (Vrang et al., 1995).”
Method
Cited by
Neuropharmacology of alcohol addiction
Vengeliene, V, Bilbao, A., Molander, A., & Spanagel, R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.30 · Cited by 571
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
HEILIG, M., & EGLI, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.001 · Cited by 377
Influence of stress associated with chronic alcohol exposure on drinking
Becker, H. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.028 · Cited by 191
Lowery-Gionta, E. G., Navarro, M., Li, C., Pleil, K. E., Rinker, J. A., Cox, B. R., Sprow, G. M., Kash, T. L., & Thiele, T. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6256-11.2012 · Cited by 149
Self-citationPartridge, J. G., Forcelli, P. A., Luo, R., Cashdan, J. M., Schulkin, J., Valentino, R. J., & Vicini, S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.029 · Cited by 81
“…to neurophysiological and behavioral 4 phenotypes associated with these states including drug and alcohol consumption 5 (Richter et al., 2000; Hayes et al., 2005; Funk et al., 2006; Lowery-Gionta et al., 2012; 6 Herman et al., 2013b; Silberman and Winder, 2013; Zorrilla et al., 2014; Herman…”
Metadata
- Authors
- Hayes, D. M., Knapp, D. J., Breese, G. R., & Thiele, T. E.
- Venue
- Alcoholism: Clinical & Experimental Research
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 29
- Issue
- 5
- Pages
- 721-729
- ISSN
- 0145-6008 (ISSN-L)
- OpenAlex
- W2088174118
- Cited by
- 52
- References
- 12
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of Basal Neuropeptide Y and Corticotropin Releasing Factor Levels Between the High Ethanol Drinking C57BL/6J and Low Ethanol Drinking DBA/2J Inbred Mouse Strains. https://app.cochat.ai/papers/10.1097/01.alc.0000164375.16838.f3
- The paper
- Hayes, D. M., Knapp, D. J., Breese, G. R., & Thiele, T. E. (2005). Comparison of Basal Neuropeptide Y and Corticotropin Releasing Factor Levels Between the High Ethanol Drinking C57BL/6J and Low Ethanol Drinking DBA/2J Inbred Mouse Strains. Alcoholism: Clinical & Experimental Research. https://doi.org/10.1097/01.alc.0000164375.16838.f3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.